THE WHAT? L’Oréal and Dutch biotech firm Micreos have announced the signing of a license agreement to join their expertise in biotechnology and the skin microbiome.

THE DETAILS Under the deal, Micreos will grant the French beauty giant access to its endolysin, a type of active protein in the cosmetic field that will enable to the creation of products targeted to eliminate only unwanted bacteria, while preserving beneficial bugs.